BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19747635)

  • 1. Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group.
    Faraci M; Bagnasco F; Corti P; Messina C; Fagioli F; Podda M; Prete A; Caselli D; Lanino E; Dini G; Rondelli R; Haupt R;
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1271-6. PubMed ID: 19747635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases.
    Bordigoni P; Turello R; Clement L; Lascombes P; Leheup B; Galloy MA; Plenat F
    Bone Marrow Transplant; 2002 Apr; 29(7):611-4. PubMed ID: 11979312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group.
    Cesaro S; Brugiolo A; Faraci M; Uderzo C; Rondelli R; Favre C; Zecca M; Garetto G; Dini G; Pillon M; Messina C; Zanesco L; Pession A; Locatelli F
    Bone Marrow Transplant; 2003 Nov; 32(9):925-31. PubMed ID: 14561994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience.
    Berman JN; Wang M; Berry W; Neuberg DS; Guinan EC
    Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
    Bailey HK; Kappy MS; Giller RH; Gralla J
    Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
    Gallagher G; Forrest DL
    Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies.
    Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
    Bone Marrow Transplant; 1998 Feb; 21(3):281-6. PubMed ID: 9489651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation.
    Petropoulou AD; Porcher R; Herr AL; Devergie A; Brentano TF; Ribaud P; Pinto FO; Rocha V; Peffault de Latour R; Orcel P; Socié G; Robin M
    Transplantation; 2010 Jun; 89(11):1354-61. PubMed ID: 20216480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
    Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
    Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and treatment of hemorrhagic cystitis in children who underwent hematopoietic stem cell transplantation.
    Cheuk DK; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
    Transpl Int; 2007 Jan; 20(1):73-81. PubMed ID: 17181656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
    Faraci M; Barra S; Cohen A; Lanino E; Grisolia F; Miano M; Foppiano F; Sacco O; Cabria M; De Marco R; Stella G; Dallorso S; Bagnasco F; Vitale V; Dini G; Haupt R
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1568-75. PubMed ID: 15990246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy.
    Faraci M; Calevo MG; Lanino E; Caruso S; Messina C; Favr C; Iori A; Santaron S; Bonanomi S; Rondelli R; Dini G; Haupt R;
    Haematologica; 2006 Aug; 91(8):1096-9. PubMed ID: 16885050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
    Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant.
    Cheuk DK; Ha SY; Lee SL; Chan GC; Tsoi NS; Lau YL
    Hematol Oncol; 2004 Mar; 22(1):1-9. PubMed ID: 15152366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.
    Gurney JG; Ness KK; Rosenthal J; Forman SJ; Bhatia S; Baker KS
    Cancer; 2006 Mar; 106(6):1402-8. PubMed ID: 16453335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor analysis of bloodstream infection in pediatric patients after hematopoietic stem cell transplantation.
    Sarashina T; Yoshida M; Iguchi A; Okubo H; Toriumi N; Suzuki D; Sano H; Kobayashi R
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):76-80. PubMed ID: 22995926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.